###begin article-title 0
###xml 4 13 4 13 <italic>Moraxella</italic>
###xml 41 46 <span type="species:ncbi:9606">human</span>
The Moraxella adhesin UspA1 binds to its human CEACAM1 receptor by a deformable trimeric coiled-coil
###end article-title 0
###begin p 1
These authors contributed equally to this work
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission.
###end p 2
###begin p 3
###xml 0 21 0 21 <italic>Moraxella catarrhalis</italic>
###xml 0 21 <span type="species:ncbi:480">Moraxella catarrhalis</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
Moraxella catarrhalis is a ubiquitous human-specific bacterium commonly associated with upper and lower respiratory tract infections, including otitis media, sinusitis and chronic obstructive pulmonary disease. The bacterium uses an autotransporter protein UspA1 to target an important human cellular receptor carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1). Using X-ray crystallography, we show that the CEACAM1 receptor-binding region of UspA1 unusually consists of an extended, rod-like left-handed trimeric coiled-coil. Mutagenesis and binding studies of UspA1 and the N-domain of CEACAM1 have been used to delineate the interacting surfaces between ligand and receptor and guide assembly of the complex. However, solution scattering, molecular modelling and electron microscopy analyses all indicate that significant bending of the UspA1 coiled-coil stalk also occurs. This explains how UspA1 can engage CEACAM1 at a site far distant from its head group, permitting closer proximity of the respective cell surfaces during infection.
###end p 3
###begin p 4
###xml 0 21 0 21 <italic>Moraxella catarrhalis</italic>
###xml 23 25 23 25 <italic>Mx</italic>
###xml 269 297 269 297 <xref ref-type="bibr" rid="b16">Karalus and Campagnari, 2000</xref>
###xml 538 540 538 540 <italic>Mx</italic>
###xml 0 21 <span type="species:ncbi:480">Moraxella catarrhalis</span>
###xml 23 25 <span type="species:ncbi:480">Mx</span>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 216 224 <span type="species:ncbi:9606">patients</span>
###xml 538 540 <span type="species:ncbi:480">Mx</span>
Moraxella catarrhalis (Mx) is a human-specific bacterium present in the nasopharynx of up to 75% of healthy individuals, but frequently causes childhood otitis media, sinusitis and exacerbation of lung conditions in patients with chronic obstructive pulmonary disease (Karalus and Campagnari, 2000). As such, it is associated with widespread morbidity. However, there are no protective vaccines and antibiotic resistance is an increasing problem. Understanding the molecular events that facilitate the complex virulence mechanisms during Mx infection is key to the development of novel therapeutics and vaccines.
###end p 4
###begin p 5
###xml 41 50 41 50 <italic>Moraxella</italic>
###xml 192 220 192 220 <xref ref-type="bibr" rid="b16">Karalus and Campagnari, 2000</xref>
###xml 235 237 235 237 <italic>Mx</italic>
###xml 447 452 447 452 <italic>et al</italic>
###xml 441 458 441 458 <xref ref-type="bibr" rid="b22">Linke <italic>et al</italic>, 2006</xref>
###xml 495 518 495 518 <italic>Yersinia enterocolitica</italic>
###xml 529 551 529 551 <italic>Haemophilus influenzae</italic>
###xml 553 555 553 555 <italic>Hi</italic>
###xml 614 616 614 616 <italic>Mx</italic>
###xml 708 713 708 713 <italic>et al</italic>
###xml 703 719 703 719 <xref ref-type="bibr" rid="b1">Aebi <italic>et al</italic>, 1998</xref>
###xml 732 737 732 737 <italic>et al</italic>
###xml 721 743 721 743 <xref ref-type="bibr" rid="b20">Lafontaine <italic>et al</italic>, 2000</xref>
###xml 749 754 749 754 <italic>et al</italic>
###xml 745 760 745 760 <xref ref-type="bibr" rid="b48">Yeo <italic>et al</italic>, 2004</xref>
###xml 768 773 768 773 <italic>et al</italic>
###xml 762 779 762 779 <xref ref-type="bibr" rid="b2">Attia <italic>et al</italic>, 2005</xref>
###xml 781 803 781 803 <xref ref-type="bibr" rid="b12">Heise and Dersch, 2006</xref>
###xml 997 1014 997 1014 <xref ref-type="bibr" rid="b11">Hammarstrom, 1999</xref>
###xml 1062 1082 1062 1082 <xref ref-type="bibr" rid="b14">Hill and Virji, 2003</xref>
###xml 1195 1200 1195 1200 <italic>et al</italic>
###xml 1190 1206 1190 1206 <xref ref-type="bibr" rid="b13">Hill <italic>et al</italic>, 2005</xref>
###xml 1364 1369 1364 1369 <italic>et al</italic>
###xml 1358 1375 1358 1375 <xref ref-type="bibr" rid="b41">Virji <italic>et al</italic>, 1996</xref>
###xml 1382 1387 1382 1387 <italic>et al</italic>
###xml 1377 1393 1377 1393 <xref ref-type="bibr" rid="b13">Hill <italic>et al</italic>, 2005</xref>
###xml 1438 1440 1438 1440 <italic>Mx</italic>
###xml 1442 1464 1442 1464 <italic>Neisseria meningitidis</italic>
###xml 1466 1468 1466 1468 <italic>Nm</italic>
###xml 1474 1476 1474 1476 <italic>Hi</italic>
###xml 1620 1625 1620 1625 <italic>et al</italic>
###xml 1614 1631 1614 1631 <xref ref-type="bibr" rid="b40">Virji <italic>et al</italic>, 1999</xref>
###xml 1633 1653 1633 1653 <xref ref-type="bibr" rid="b14">Hill and Virji, 2003</xref>
###xml 1665 1670 1665 1670 <italic>et al</italic>
###xml 1655 1676 1655 1676 <xref ref-type="bibr" rid="b9">Griffiths <italic>et al</italic>, 2007</xref>
###xml 1688 1693 1688 1693 <italic>et al</italic>
###xml 1678 1699 1678 1699 <xref ref-type="bibr" rid="b39">Villullas <italic>et al</italic>, 2007</xref>
###xml 1769 1785 1769 1785 <italic>Escherichia coli</italic>
###xml 1790 1800 1790 1800 <italic>Salmonella</italic>
###xml 1809 1814 1809 1814 <italic>et al</italic>
###xml 1802 1820 1802 1820 <xref ref-type="bibr" rid="b21">Leusch <italic>et al</italic>, 1991</xref>
###xml 1830 1835 1830 1835 <italic>et al</italic>
###xml 1822 1841 1822 1841 <xref ref-type="bibr" rid="b10">Guignot <italic>et al</italic>, 2000</xref>
###xml 1935 1940 1935 1940 <italic>et al</italic>
###xml 1926 1946 1926 1946 <xref ref-type="bibr" rid="b6">Dveksler <italic>et al</italic>, 1993</xref>
###xml 2002 2011 2002 2011 <sup>(527&#8211;665)</sup>
###xml 2143 2145 2143 2145 <italic>Nm</italic>
###xml 2150 2152 2150 2152 <italic>Hi</italic>
###xml 2220 2222 2220 2222 <italic>Mx</italic>
###xml 2242 2247 2242 2247 <italic>et al</italic>
###xml 2237 2253 2237 2253 <xref ref-type="bibr" rid="b13">Hill <italic>et al</italic>, 2005</xref>
###xml 235 237 <span type="species:ncbi:480">Mx</span>
###xml 381 384 <span type="species:ncbi:50475">Oca</span>
###xml 495 518 <span type="species:ncbi:630">Yersinia enterocolitica</span>
###xml 529 551 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 553 555 <span type="species:ncbi:727">Hi</span>
###xml 614 616 <span type="species:ncbi:480">Mx</span>
###xml 810 815 <span type="species:ncbi:9606">human</span>
###xml 1300 1305 <span type="species:ncbi:9606">human</span>
###xml 1438 1440 <span type="species:ncbi:480">Mx</span>
###xml 1442 1464 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 1466 1468 <span type="species:ncbi:487">Nm</span>
###xml 1474 1476 <span type="species:ncbi:727">Hi</span>
###xml 1769 1785 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1855 1861 <span type="species:ncbi:10090">murine</span>
###xml 1903 1924 <span type="species:ncbi:11138">mouse hepatitis virus</span>
###xml 2143 2145 <span type="species:ncbi:487">Nm</span>
###xml 2150 2152 <span type="species:ncbi:727">Hi</span>
###xml 2165 2170 <span type="species:ncbi:9606">human</span>
###xml 2220 2222 <span type="species:ncbi:480">Mx</span>
Infection by pathogenic bacteria such as Moraxella is initiated by multifunctional bacterial surface adhesin proteins that may additionally act in defensive roles to evade immune recognition (Karalus and Campagnari, 2000). A number of Mx adhesins have been identified and characterised from non-fimbriate (non-piliated) bacteria. These include the oligomeric coiled-coil adhesins (Oca, also recently classified as trimeric autotransporters; Linke et al, 2006) such as YadA from enteropathogenic Yersinia enterocolitica, Hia from Haemophilus influenzae (Hi) and the ubiquitous surface proteins UspA1 and UspA2 from Mx. A range of studies have confirmed the importance of these molecules in pathogenesis (Aebi et al, 1998; Lafontaine et al, 2000; Yeo et al, 2004; Attia et al, 2005; Heise and Dersch, 2006). The human carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), which is widely distributed on epithelial cells including those of the oropharynx and lower respiratory tracts (Hammarstrom, 1999), has been identified as a receptor for UspA1 (Hill and Virji, 2003). Other members of the CEACAM receptor family expressed on epithelia (CEA and CEACAM6) also bind to UspA1 (Hill et al, 2005), although these are less well studied. Over the past decade CEACAM1 has emerged as a common human receptor targeted by several respiratory pathogens (Virji et al, 1996; Hill et al, 2005). These include the opportunistic pathogens Mx, Neisseria meningitidis (Nm) and Hi, all of which interact with an overlapping site in the N-terminal domain of the receptor (N-CEACAM1) often leading to cellular invasion (Virji et al, 1999; Hill and Virji, 2003; Griffiths et al, 2007; Villullas et al, 2007). In addition, CEACAM1 is bound by strains of enterobacteria such as Escherichia coli and Salmonella (Leusch et al, 1991; Guignot et al, 2000) and several murine CEACAM1a isoforms serve as receptors for mouse hepatitis virus (Dveksler et al, 1993). A recombinant protein rD-7 (here referred to as UspA1(527-665)) based on this region of UspA1 has been shown to block binding of multiple respiratory pathogens, virtually eliminating binding of Nm and Hi isolates to human lung epithelial cells and substantially reducing Mx interactions (Hill et al, 2005). An antiadhesion strategy targeting N-CEACAM1 may therefore provide a unified approach to control infections caused by these pathogens and an alternative to antibiotic treatment.
###end p 5
###begin p 6
###xml 220 225 220 225 <italic>et al</italic>
###xml 212 231 212 231 <xref ref-type="bibr" rid="b15">Hoiczyk <italic>et al</italic>, 2000</xref>
###xml 308 313 308 313 <italic>et al</italic>
###xml 303 319 303 319 <xref ref-type="bibr" rid="b4">Cope <italic>et al</italic>, 1999</xref>
###xml 856 861 856 861 <italic>et al</italic>
###xml 847 867 847 867 <xref ref-type="bibr" rid="b29">Nummelin <italic>et al</italic>, 2004</xref>
###xml 882 887 882 887 <italic>et al</italic>
###xml 878 893 878 893 <xref ref-type="bibr" rid="b48">Yeo <italic>et al</italic>, 2004</xref>
###xml 926 931 926 931 <italic>et al</italic>
###xml 921 937 921 937 <xref ref-type="bibr" rid="b26">Meng <italic>et al</italic>, 2006</xref>
###xml 1024 1029 1024 1029 <italic>et al</italic>
###xml 1016 1035 1016 1035 <xref ref-type="bibr" rid="b18">Koretke <italic>et al</italic>, 2006</xref>
###xml 1046 1051 1046 1051 <italic>et al</italic>
###xml 1037 1057 1037 1057 <xref ref-type="bibr" rid="b46">Wollmann <italic>et al</italic>, 2006</xref>
###xml 1257 1262 1257 1262 <italic>et al</italic>
###xml 1251 1268 1251 1268 <xref ref-type="bibr" rid="b30">Oomen <italic>et al</italic>, 2004</xref>
###xml 1743 1748 1737 1742 <italic>et al</italic>
###xml 1735 1754 1729 1748 <xref ref-type="bibr" rid="b15">Hoiczyk <italic>et al</italic>, 2000</xref>
Electron microscopy studies have shown that YadA, UspA1 and UspA2 form dense forests of lollipop-like structures at the bacterial surface projecting from 200 A (YadA) to 600-700 A (UspA1) from the cell membrane (Hoiczyk et al, 2000). The UspAs have been shown by SDS-PAGE to form oligomeric structures (Cope et al, 1999). Amino-acid sequence comparisons have identified similar domains in YadA, Hia, UspA1 and UspA2 despite the considerable variations in their respective sizes (monomer masses are YadA 41-43 kDa, Hia 100-125 kDa, UspA1 88-100 kDa and UspA2 60-71 kDa). Each adhesin has a tripartite structure consisting of a head group, extended stalk region and membrane anchor domain. Although, up to now, no detailed structural information has been available for the UspAs, crystal structures have been reported for the head groups from YadA (Nummelin et al, 2004) and Hia (Yeo et al, 2004), the Hia membrane domain (Meng et al, 2006) and a theoretical model has been proposed for the overall structure of YadA (Koretke et al, 2006; Wollmann et al, 2006). In this model, the stalk has been proposed to adopt a trimeric coiled-coil structure with the C-terminal membrane anchor domain based on the crystal structure of a bacterial autotransporter (Oomen et al, 2004). This model has been supported by the crystal structure of the Hia membrane domain, which is constructed from four beta-strands contributed from each of three monomers; the resulting 12-stranded beta-barrel ensures trimerisation of the structure. Amino-acid sequence comparisons indicate that the UspAs differ most significantly from YadA in the length of both their head groups and stalk regions, and in the periodicity and handedness of the proposed coiled-coil (Hoiczyk et al, 2000).
###end p 6
###begin p 7
###xml 120 128 120 128 <xref ref-type="fig" rid="f1">Figure 1</xref>
###xml 180 185 180 185 <italic>et al</italic>
###xml 176 191 176 191 <xref ref-type="bibr" rid="b37">Tan <italic>et al</italic>, 2005</xref>
###xml 210 215 210 215 <italic>et al</italic>
###xml 206 221 206 221 <xref ref-type="bibr" rid="b36">Tan <italic>et al</italic>, 2006</xref>
###xml 513 518 513 518 <italic>et al</italic>
###xml 508 524 508 524 <xref ref-type="bibr" rid="b1">Aebi <italic>et al</italic>, 1998</xref>
###xml 606 611 606 611 <italic>et al</italic>
###xml 596 617 596 617 <xref ref-type="bibr" rid="b28">Nordstrom <italic>et al</italic>, 2004</xref>
###xml 774 779 774 779 <italic>et al</italic>
###xml 769 785 769 785 <xref ref-type="bibr" rid="b13">Hill <italic>et al</italic>, 2005</xref>
###xml 885 890 885 890 <italic>et al</italic>
###xml 877 896 877 896 <xref ref-type="bibr" rid="b18">Koretke <italic>et al</italic>, 2006</xref>
###xml 961 969 961 969 <xref ref-type="fig" rid="f1">Figure 1</xref>
###xml 1418 1420 1418 1420 <italic>Mx</italic>
###xml 1620 1625 1620 1625 <italic>et al</italic>
###xml 1609 1631 1609 1631 <xref ref-type="bibr" rid="b8">Fedarovich <italic>et al</italic>, 2006</xref>
###xml 1418 1420 <span type="species:ncbi:480">Mx</span>
UspA adhesins are multi-functional proteins for which a range of binding functions have been reported (see schematic in Figure 1). These include binding sites for fibronectin (Tan et al, 2005) and laminin (Tan et al, 2006), both in the N-terminal end of the UspAs where they are likely to be furthermost from the bacterial membrane and therefore most readily available for attachment. Serum resistance is also associated with UspA proteins as UspA2 contains a complement C3-binding region (regions 200-458) (Aebi et al, 1998) and both UspA1 and UspA2 bind to the complement binding protein C4bp (Nordstrom et al, 2004). Importantly, UspA1 has been shown to include a critical binding site for CEACAM1 away from the head group within residues 527-667 of the MX2 strain (Hill et al, 2005). In the extended 600- to 700-A-long structure expected for UspA1 based on the YadA model (Koretke et al, 2006) this is expected to be at least 400 A from the head group (see Figure 1). In contrast, the predicted four immunoglobulin superfamily extracellular domains of CEACAM1 could project only just over 100 A from the epithelial cell surface. Matching of these regions and sufficiently close approach of the bacterial and host cell membranes to allow adhesion and infection to proceed would therefore appear difficult. In view of this apparent disparity and to explore the crucial importance of the UspA1-CEACAM1 interaction to Mx pathogenicity, in this study we have initially determined the structure of the CEACAM1 receptor-binding site in UspA1. This has then been combined with the crystal structure of N-CEACAM1 (Fedarovich et al, 2006) to reveal the structure of the CEACAM1:UspA1 complex, assembled using a complementary approach combining data from crystallographic, mutagenesis and small-angle X-ray scattering (SAXS) techniques.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
The UspA1 CEACAM1-binding site is part of an extended trimeric coiled-coil
###end title 9
###begin p 10
###xml 149 158 149 158 <sup>(527&#8211;665)</sup>
###xml 284 289 284 289 <italic>et al</italic>
###xml 276 295 276 295 <xref ref-type="bibr" rid="b15">Hoiczyk <italic>et al</italic>, 2000</xref>
###xml 303 312 303 312 <sup>(527&#8211;665)</sup>
###xml 404 412 404 412 <xref ref-type="fig" rid="f2">Figure 2</xref>
###xml 827 841 827 841 <italic>M. catarrhalis</italic>
###xml 827 841 <span type="species:ncbi:480">M. catarrhalis</span>
Initially, to probe the structural basis of the bacterial ligand-host receptor interaction, we determined the crystallographic structure of the UspA1(527-665) fragment. Although this region incorporates several regions with predicted low propensity for coiled-coil formation (Hoiczyk et al, 2000), UspA1(527-665) was found to form a contiguous, extended coiled-coil structure within the crystal lattice (Figure 2). Whereas earlier estimates of UspA1 oligomer composition were ambiguous, the crystal structure confirms that three polypeptide strands coalesce to form a left-handed trimeric coiled-coil. In each chain, there is clear electron density for 135 of the 139 amino acids with four residues (527-530) being disordered at the N terminus of each chain (this and all subsequent sequence numbering refers to UspA1 from the M. catarrhalis MX2 strain). As the trimer lies along the crystallographic three-fold axis, the conformation of each monomer within the trimer is identical. There are two monomers within the asymmetric unit and both are highly similar (root mean square deviation of all equivalent Calpha's=1.3 A). The resulting rod-like structure is approximately 200 A long and 20 A in diameter.
###end p 10
###begin p 11
###xml 23 32 23 32 <sup>(527&#8211;665)</sup>
###xml 284 295 284 295 <xref ref-type="bibr" rid="b24">Lupas, 1996</xref>
###xml 354 360 354 360 <italic>SOCKET</italic>
###xml 362 388 362 388 <xref ref-type="bibr" rid="b43">Walshaw and Woolfson, 2001</xref>
###xml 550 559 544 553 <sup>(527&#8211;665)</sup>
###xml 713 714 707 708 <italic>a</italic>
###xml 719 720 713 714 <italic>d</italic>
###xml 749 760 743 754 <xref ref-type="bibr" rid="b24">Lupas, 1996</xref>
###xml 955 956 949 950 <italic>d</italic>
###xml 1047 1048 1041 1042 <italic>a</italic>
###xml 1117 1118 1111 1112 <italic>d</italic>
###xml 1375 1390 1369 1384 <xref ref-type="fig" rid="f2">Figure 2B and C</xref>
To our knowledge, UspA1(527-665) forms the longest segment of triple coiled-coil for which a high-resolution structure has been determined. Overall, the average periodicity of the coil is 3.5 residues per turn with a pitch of about 150 A, close to the expected hypothetical geometry (Lupas, 1996). Analysis of the structure with the coiled-coil software SOCKET (Walshaw and Woolfson, 2001) identified 84 'knobs into holes' interactions; all are of type 4 with packing angles of between 45 and 60degrees as commonly observed in trimers. Although UspA1(527-665) appears to adopt a classic trimeric coiled-coil structure, there are a number of surprises. Whereas most of the internal hydrophobic residues (positions a and d by the standard convention; Lupas, 1996) are a mixture of alanines, isoleucines, valines and asparagines-as expected for trimeric coiled-coils-this pattern is disrupted at residue 573 when, unusually, a histidine is incorporated at a d position within the core. This is seen again three turns later at histidine 584 (position a) and then further after another 12 turns at histidine 629 (position d). For both histidines 584 and 629, the potential charge these residues incorporate within the core appears to be ameliorated through the incorporation of a bound phosphate ion. These ions are located equidistant (3.0 A) from the histidine of each monomer (Figure 2B and C). The histidine rings are partially orientated through formation of a bifurcated hydrogen bond between each phosphate oxygen, a bound water, the main chain carbonyl group of Leu 580 (at His 584) and interactions with the neighbouring side chain of Ser 630 (at His 629). It is not clear whether binding of these phosphate ions, presumably from the crystallisation buffer, is biologically relevant.
###end p 11
###begin p 12
###xml 110 119 110 119 <xref ref-type="fig" rid="f2">Figure 2D</xref>
###xml 233 234 233 234 <italic>d</italic>
###xml 501 506 501 506 <italic>et al</italic>
###xml 497 512 497 512 <xref ref-type="bibr" rid="b38">Tao <italic>et al</italic>, 1997</xref>
###xml 578 583 578 583 <italic>et al</italic>
###xml 568 589 568 589 <xref ref-type="bibr" rid="b5">Duquerroy <italic>et al</italic>, 2005</xref>
###xml 550 566 <span type="species:ncbi:227859">SARS coronavirus</span>
We also observe density consistent with eight chloride ions bound within the central core of the coiled-coil (Figure 2D). These are present when an asparagine residue is encountered in the central cavity of the coiled-coil (position d), and in each instance the ions interact via the amide nitrogen of the asparagine side chain with distances ranging from 3.1 to 3.2 A. Chloride ions have been observed previously in the central core of a number of similar structures including those of fibritin (Tao et al, 1997) and the spike glycoprotein from the SARS coronavirus (Duquerroy et al, 2005) and are proposed to add specificity in aligning the individual monomers of the coiled-coil.
###end p 12
###begin p 13
Finally, the degree of helical supercoiling relaxes towards the C terminus where there is a stutter in the sequence starting from Ser 657 (three residues of the heptad appear to be missing) and a decrease in supercoiling is evident. Because of the breakdown in the pattern of core hydrophobic residues, this distortion is likely to be inherent within the sequence rather than a response to the artificial truncation of the coiled-coil within this recombinant construct.
###end p 13
###begin title 14
Stability of the coiled-coil stalk
###end title 14
###begin p 15
###xml 398 407 398 407 <sup>(527&#8211;665)</sup>
###xml 438 446 438 446 <xref ref-type="fig" rid="f3">Figure 3</xref>
The unexpected incorporation of potentially charged histidine side chains within the hydrophobic core of the trimeric assembly led us to speculate that protonation of these groups might provide a mechanism for destabilisation of the assembly, hence potentially initiating or assisting flexibility within the rod-like structure. Circular dichroism (CD) was used to assay the helical content of UspA1(527-665) in response to changes in pH (Figure 3). These data indicated a sharp transition from a helical folded structure (assumed to be coiled-coil) to random coil once the pH dropped below 4.8. Protonation of the histidine side chains (normally expected to occur at pH 6, but often reduced in hydrophobic core regions), introducing repulsive positive charges within the core of the trimer, would be expected to be incompatible with trimer assembly. However, these data also confirm that the coiled-coil form must prevail at physiological pH.
###end p 15
###begin title 16
###xml 5 14 5 14 <sup>(527&#8211;665)</sup>
UspA1(527-665) forms a stable complex with N-CEACAM1
###end title 16
###begin p 17
###xml 123 131 123 131 <xref ref-type="fig" rid="f4">Figure 4</xref>
###xml 237 246 237 246 <sup>(527&#8211;665)</sup>
###xml 310 319 310 319 <sup>(527&#8211;665)</sup>
###xml 400 409 400 409 <sup>(527&#8211;665)</sup>
###xml 647 652 647 652 <italic>et al</italic>
###xml 642 658 642 658 <xref ref-type="bibr" rid="b44">Watt <italic>et al</italic>, 2001</xref>
###xml 661 670 661 670 <xref ref-type="fig" rid="f4">Figure 4A</xref>
###xml 693 702 693 702 <sup>(527&#8211;665)</sup>
###xml 897 906 897 906 <xref ref-type="fig" rid="f4">Figure 4B</xref>
###xml 999 1008 999 1008 <sup>(527&#8211;665)</sup>
###xml 1132 1137 1132 1137 <italic>et al</italic>
###xml 1124 1143 1124 1143 <xref ref-type="bibr" rid="b17">Kegeles <italic>et al</italic>, 1967</xref>
###xml 1336 1345 1336 1345 <sup>(527&#8211;665)</sup>
###xml 1489 1498 1489 1498 <sup>(527&#8211;665)</sup>
###xml 1550 1555 1550 1555 <italic>et al</italic>
###xml 1545 1561 1545 1561 <xref ref-type="bibr" rid="b44">Watt <italic>et al</italic>, 2001</xref>
###xml 1606 1615 1606 1615 <xref ref-type="fig" rid="f4">Figure 4C</xref>
###xml 1666 1675 1666 1675 <sup>(527&#8211;665)</sup>
###xml 1727 1728 1727 1728 <italic>N</italic>
###xml 1770 1771 1768 1769 <italic>K</italic>
###xml 1771 1772 1769 1770 <sub>D</sub>
###xml 2022 2031 2018 2027 <sup>(527&#8211;665)</sup>
Next, we used gel permeation chromatography (GPC), analytical ultracentrifugation (AUC) equilibrium sedimentation studies (Figure 4) and isothermal calorimetry (ITC) to confirm that N-CEACAM1 forms a stable complex in solution with UspA1(527-665). In all cases, self-aggregation and the extended shape of UspA1(527-665) lead to non-ideal behaviour, complicating the data interpretation. On GPC, UspA1(527-665) runs anomalously, eluting with an apparent molecular mass of 110 kDa (expected mass of trimer 45 494), whereas N-CEACAM1 (expected mass 11 747) appeared to be 19.5 kDa, perhaps reflecting its known propensity for homo-dimerisation (Watt et al, 2001) (Figure 4A). The complex of UspA1(527-665) with N-CEACAM1 eluted with an apparent molecular mass of 150 kDa; this peak broadening on the addition of excess N-CEACAM1. Similarly, global fit analysis of sedimentation equilibrium AUC data (Figure 4B) indicated a mass of 27 237 for N-CEACAM1 suggesting a dimer, and a mass of 43 896 for UspA1(527-665) indicative of a trimer. Determination of the mass of their complex was complicated by pronounced pressure effects (Kegeles et al, 1967) that lead to a reduction in observed apparent mass at higher speeds. Global fit analysis of the lower speed data for the complex gave a mass of 74 162, which appears consistent with one UspA1(527-665) trimer binding either one N-CEACAM1 dimer or two monomers, although lower masses were obtained from the higher speed data. Aggregation of UspA1(527-665) and competing homo-dimerisation of N-CEACAM1 (Watt et al, 2001) also affected the quality of the ITC data (Figure 4C). However, these data confirm each trimer of UspA1(527-665) can readily bind up to two molecules of N-CEACAM1 (N=2.0+/-0.2) with high affinity (estimated KD 24+/-22 nM), after which only weak, possibly nonspecific, further association is observed. Taking into account the limitations of each of these techniques in analysing this complex association event, in summary we concluded that each trimer of UspA1(527-665) provides a high-affinity binding site for a maximum of two molecules of N-CEACAM1.
###end p 17
###begin title 18
Location of the receptor-binding site on UspA1
###end title 18
###begin p 19
###xml 60 69 60 69 <sup>(527&#8211;665)</sup>
###xml 89 98 89 98 <xref ref-type="fig" rid="f2">Figure 2E</xref>
###xml 489 498 489 498 <xref ref-type="fig" rid="f2">Figure 2E</xref>
An electrostatic potential surface calculated from the UspA1(527-665) crystal structure (Figure 2E) displayed a predominance of anionic and cationic regions on the solvent-accessible coiled-coil surface. However, one section of the coiled-coil was striking for its deviation from this pattern. The segment 578-597 contains only one charged residue-histidine 584-which is buried within the hydrophobic core (see above). The exterior surface of this segment is notably hydrophobic (white in Figure 2E). This region is located just over one-third of the way along the rod-like structure, approximately 80 A from the N terminus.
###end p 19
###begin p 20
###xml 125 127 125 127 <italic>Mx</italic>
###xml 173 191 173 191 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 420 429 420 429 <xref ref-type="fig" rid="f5">Figure 5A</xref>
###xml 851 869 851 869 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 1035 1044 1035 1044 <xref ref-type="fig" rid="f3">Figure 3B</xref>
###xml 1165 1174 1159 1168 <xref ref-type="fig" rid="f3">Figure 3C</xref>
###xml 125 127 <span type="species:ncbi:480">Mx</span>
As this distinctive patch also overlapped with a normally highly conserved region, which is unusually absent in the UspA1 of Mx O35E strain that does not bind to N-CEACAM1 (Supplementary data), site-directed mutants of surface residues both within and adjacent to this region were prepared. Each of the mutants was selected and designed to have minimal impact on the coiled-coil formation. The mutants made are shown in Figure 5A and include changes to amino acids expected to be exposed at the binding interface (L583A, M586A, A588Q and A590Q), a double mutation (M586A/A588Q) and a control substitution (A568Q) from outside the predicted region of the N-CEACAM1 interaction. Western blotting was used to confirm that in each case the purified mutant protein retained the ability to form trimers indicative of retention of the coiled-coil structure (Supplementary data). This was further confirmed for the double mutant (M586A/A588Q) where the CD spectra of both the native and mutant proteins were found to be essentially identical (Figure 3B) and only a minor thermodynamic difference was observed in their melting temperatures (41 and 39degreesC, respectively; Figure 3C). These observations confirm that the amino-acid substitutions introduced do not affect the structure or assembly of the coiled-coil, indicating that altered binding effects are likely to arise from direct contacts of these amino acids with N-CEACAM1 rather than by disruption of the UspA1 gross structure.
###end p 20
###begin p 21
###xml 33 42 33 42 <sup>(527&#8211;665)</sup>
###xml 117 126 117 126 <xref ref-type="fig" rid="f5">Figure 5B</xref>
###xml 205 214 205 214 <sup>(527&#8211;665)</sup>
###xml 564 573 564 573 <xref ref-type="fig" rid="f5">Figure 5B</xref>
###xml 725 734 725 734 <xref ref-type="fig" rid="f5">Figure 5C</xref>
The ability of these mutant UspA1(527-665) proteins to bind CEACAM1-Fc was measured in an ELISA and is summarised in Figure 5B. No significant difference in binding was observed between the wild-type UspA1(527-665) and the control construct (A568Q) at any of the concentrations tested. At limiting CEACAM1 concentration, decreased CEACAM1 binding was observed at one or more UspA1 concentrations for all of the other constructs. The most striking effect on CEACAM binding was observed for the mutants L583A, M586A, A590Q and the double substitution (M586A/A588Q) (Figure 5B). Comparable binding of anti-polyhistidine antibody was observed to all constructs confirming equivalent coating of all constructs to the ELISA plate (Figure 5C, ii). These studies indicated that the order of importance of single UspA1 residues involved in CEACAM1 engagement appears to be L583>A590>M586>A588.
###end p 21
###begin p 22
###xml 82 91 82 91 <sup>(527&#8211;665)</sup>
###xml 170 179 170 179 <xref ref-type="fig" rid="f5">Figure 5C</xref>
###xml 254 263 254 263 <sup>(527&#8211;665)</sup>
These binding data were also supported by western blotting analysis in which UspA1(527-665) constructs were overlaid with CEACAM1-Fc and detected by an anti-Fc antibody (Figure 5C). In these assays, no decrease in binding was evident between native UspA1(527-665), the A568Q control or the A588Q substitution. A decrease in CEACAM1 binding was observed to M586A (14.8%), A590Q (15.0%), L583A (92.0%) and the double substitution (90.4%). These data parallel the ELISA data and affirm the relative importance of UspA1 residues involved in CEACAM1 engagement as L583>A590>M586>A588. It is interesting to note that in both ELISA studies and western blot analysis the double substitution M586A/A588Q abrogates binding and this appears to be a synergistic effect in both techniques. Such data highlight the importance of multiple amino-acid engagement in the interaction of UspA1 and CEACAM1.
###end p 22
###begin title 23
The UspA1-binding site on its CEACAM1 receptor
###end title 23
###begin p 24
###xml 138 140 138 140 <italic>Nm</italic>
###xml 145 147 145 147 <italic>Hi</italic>
###xml 254 259 254 259 <italic>et al</italic>
###xml 248 265 248 265 <xref ref-type="bibr" rid="b40">Virji <italic>et al</italic>, 1999</xref>
###xml 277 282 277 282 <italic>et al</italic>
###xml 267 288 267 288 <xref ref-type="bibr" rid="b39">Villullas <italic>et al</italic>, 2007</xref>
###xml 382 384 382 384 <italic>Nm</italic>
###xml 389 391 389 391 <italic>Hi</italic>
###xml 403 405 403 405 <italic>Mx</italic>
###xml 407 427 407 427 <xref ref-type="bibr" rid="b14">Hill and Virji, 2003</xref>
###xml 451 460 451 460 <sup>(527&#8211;665)</sup>
###xml 517 522 517 522 <italic>et al</italic>
###xml 512 528 512 528 <xref ref-type="bibr" rid="b13">Hill <italic>et al</italic>, 2005</xref>
###xml 663 665 663 665 <italic>Nm</italic>
###xml 670 672 670 672 <italic>Hi</italic>
###xml 830 839 830 839 <sup>(527&#8211;665)</sup>
###xml 1081 1090 1081 1090 <xref ref-type="fig" rid="f5">Figure 5A</xref>
###xml 1095 1113 1095 1113 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 1294 1299 1294 1299 <italic>et al</italic>
###xml 1289 1305 1289 1305 <xref ref-type="bibr" rid="b44">Watt <italic>et al</italic>, 2001</xref>
###xml 138 140 <span type="species:ncbi:487">Nm</span>
###xml 145 147 <span type="species:ncbi:727">Hi</span>
###xml 382 384 <span type="species:ncbi:487">Nm</span>
###xml 389 391 <span type="species:ncbi:727">Hi</span>
###xml 403 405 <span type="species:ncbi:480">Mx</span>
###xml 663 665 <span type="species:ncbi:487">Nm</span>
###xml 670 672 <span type="species:ncbi:727">Hi</span>
Identification of the surface on CEACAM1 that interacts with UspA1 was facilitated by a number of prior observations: (1) other pathogens-Nm and Hi-that recognise N-CEACAM1 have been found to use a site centred on the critical CEACAM1 residue I91 (Virji et al, 1999; Villullas et al, 2007); (2) this site also forms an epitope for an anti-CEACAM1 antibody shown to block binding of Nm and Hi as well as Mx (Hill and Virji, 2003); (3) recombinant UspA1(527-665) inhibits binding of all three pathogens to CEACAM1(Hill et al, 2005). Combining these earlier results, we surmised that the UspA1-binding site must at least partially overlap with the site also used by Nm and Hi. We therefore mutated I91 and surrounding residues on CEACAM1 to define the extent of the UspA1-binding site. In ELISA studies, binding of N-CEACAM1 to UspA1(527-665) was significantly impaired when I91 was mutated to Ala, and moderate reductions in binding accompanied mutation of surrounding residues Y34, Q44 and G47, whereas little or no effect was noted for the mutations of S32, T56, V39, V96 and Q89 (Figure 5A and Supplementary data). No reduction in binding was also noted for V39A, confirming UspA1 binds to the monomeric form of CEACAM1 as this mutation has previously been shown to abolish dimerisation (Watt et al, 2001). Interestingly, the introduction of a leucine side chain to CEACAM1 position 56 partially restored binding to the UspA1 L583A mutant. From our model of the complex (see below) it was anticipated that these mutations should be compensatory.
###end p 24
###begin p 25
###xml 47 56 47 56 <sup>(527&#8211;665)</sup>
In summary, the mutagenesis data for both UspA1(527-665) and N-CEACAM1 when combined with their respective crystal structures enabled us to locate their interacting surfaces.
###end p 25
###begin title 26
###xml 19 28 19 28 <sup>(527&#8211;665)</sup>
The N-CEACAM1:UspA1(527-665) complex
###end title 26
###begin p 27
###xml 57 66 57 66 <sup>(527&#8211;665)</sup>
###xml 322 331 322 331 <xref ref-type="fig" rid="f5">Figure 5A</xref>
###xml 929 934 929 934 <italic>et al</italic>
###xml 918 940 918 940 <xref ref-type="bibr" rid="b8">Fedarovich <italic>et al</italic>, 2006</xref>
###xml 1106 1111 1106 1111 <italic>et al</italic>
###xml 1101 1117 1101 1117 <xref ref-type="bibr" rid="b44">Watt <italic>et al</italic>, 2001</xref>
###xml 1161 1179 1161 1179 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 1383 1392 1383 1392 <xref ref-type="fig" rid="f5">Figure 5A</xref>
###xml 1757 1765 1757 1765 <xref ref-type="fig" rid="f4">Figure 4</xref>
###xml 1858 1867 1858 1867 <sup>(527&#8211;665)</sup>
A tentative model for the complex of N-CEACAM1 with UspA1(527-665) was then prepared by assembling the two individual crystal structures. This preliminary model was built by comparing the respective sites identified by site-directed mutagenesis, manually assembling the two surfaces in the most complementary orientation (Figure 5A) followed by energy minimisation of the complex. This generated an interface in which the UspA1 residues M586 and A590 are in close proximity to I91 of the receptor, UspA1 A588 is adjacent to Y34, V39 and Q89 of CEACAM1 and UspA1 L583 lies next to Q44, G47 and T56 of CEACAM1. These residues form the region identified by the mutagenesis studies to affect binding. The complementary nature of these surfaces was only marred by a small protrusion of the F/G loop of N-CEACAM1, a region that is involved in a homo-dimerisation interaction around a two-fold axis in the crystal structure (Fedarovich et al, 2006). It is likely that this conformation is not maintained within the monomeric form of N-CEACAM1 which, as confirmed by the binding of the monomeric V39A mutant (Watt et al, 2001), is the active form for binding to UspA1 (Supplementary data). Although the actual conformation of the F/G loop in this form is uncertain, we noted that on energy minimisation of the complex this region protrudes into a distinctive cavity formed at the interface (Figure 5A), possibly assisting partial unwinding of the coiled-coil assembly. The surface area occupied by the N-CEACAM1 molecule is approximately one-third of the circumferential surface area in the proposed binding site region of the UspA1 trimeric structure, implying that three N-CEACAM1 molecules could bind simultaneously. This is in contrast to the AUC and ITC data (Figure 4) which show that, in practice, only two N-CEACAM1 molecules bind with high affinity to UspA1(527-665).
###end p 27
###begin title 28
Binding of receptor correlates with bending of the stalk region of UspA1
###end title 28
###begin p 29
###xml 54 63 54 63 <sup>(527&#8211;665)</sup>
###xml 172 181 172 181 <sup>(527&#8211;665)</sup>
###xml 199 208 199 208 <xref ref-type="fig" rid="f6">Figure 6A</xref>
###xml 326 335 326 335 <sup>(527&#8211;665)</sup>
###xml 511 520 511 520 <sup>(527&#8211;665)</sup>
###xml 746 747 746 747 <italic>p</italic>
###xml 748 749 748 749 <italic>r</italic>
###xml 928 929 904 905 <italic>p</italic>
###xml 930 931 906 907 <italic>r</italic>
To validate the proposed model for the N-CEACAM1/UspA1(527-665) complex, we obtained SAXS data. The scattering patterns of solutions of the complex and of uncomplexed UspA1(527-665) are presented in Figure 6A. There is further indication of the self-aggregation behaviour also noted at high concentrations of uncomplexed UspA1(527-665) in the AUC studies, and this prevented reliable interpretation of the SAXS data from the unliganded form. However, the scattering curve changes upon complex formation of UspA1(527-665) with N-CEACAM1, and is consistent with a mono-disperse solution with an estimated molecular mass that agrees well with the value predicted from the primary sequence of the expected complex. The distance distribution function p(r) of the complex suggests an elongated shape with a maximum diameter of approximately14 nm and a cross section of approximately2 nm (the latter parameter corresponds to a maximal p(r)). The experimental radius of gyration was 4.58+/-0.09 nm.
###end p 29
###begin p 30
###xml 56 65 56 65 <italic>ab initio</italic>
###xml 139 152 139 152 <xref ref-type="bibr" rid="b35">Svergun, 1999</xref>
###xml 323 347 309 333 <xref ref-type="bibr" rid="b42">Volkov and Svergun, 2003</xref>
###xml 359 367 345 353 <xref ref-type="fig" rid="f6">Figure 6</xref>
###xml 1142 1169 1122 1149 <xref ref-type="bibr" rid="b31">Petoukhov and Svergun, 2005</xref>
###xml 1381 1386 1361 1366 <italic>et al</italic>
###xml 1373 1392 1353 1372 <xref ref-type="bibr" rid="b34">Svergun <italic>et al</italic>, 1995</xref>
###xml 1517 1526 1495 1504 <sup>(527&#8211;665)</sup>
###xml 1651 1660 1627 1636 <xref ref-type="fig" rid="f6">Figure 6A</xref>
A low-resolution model of the complex was reconstructed ab initio from the experimental scattering patterns. Reconstructions using DAMMIN (Svergun, 1999) yielded similar envelopes with consistently reasonable fits to the experimental data (chi values of approximately1.5) and which could be readily superimposed (mean NSD (Volkov and Svergun, 2003) of 0.88) (Figure 6). Although the data indicate a diversity of potential fits, all of the shapes share the same essential features: the complex is seen to be elongated and is of comparable dimensions (approximately 200 A in total length, 20-30 A in diameter) to the UspA1 crystal structure. Distinctively, however, there is a significant bend in the molecule (30-60degrees deflection from the linear form in the various models), resulting in a 'boomerang' shape. Adjacent to the apex of this bend there is a thickening of the envelope, approximately sufficient to accommodate two N-CEACAM1 domains. Bending of the UspA1 rod was approximated by splitting the modelled complex into four equal lengths. These were fitted to the scattering data as separate rigid bodies using the software SASREF (Petoukhov and Svergun, 2005). A complete model of the complex was generated by rejoining of the UspA1 polypeptide chains followed by energy minimisation. This model was then fitted to the scattering data using the software CRYSOL (Svergun et al, 1995), which resulted in a chi value of 1.45. By contrast, attempts to fit the predicted scattering from a complex in which UspA1(527-665) retained a straight rod-like shape produced significantly poorer correlation with the experimental data (chi value of 3.11; Figure 6A).
###end p 30
###begin p 31
###xml 105 123 105 123 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 169 178 169 178 <sup>(527&#8211;665)</sup>
###xml 433 442 433 442 <sup>(527&#8211;665)</sup>
To explore the feasibility of this model of the complex, molecular dynamics simulations were undertaken (Supplementary data). Simulations of the unliganded form of UspA1(527-665) indicated this form, although showing some flexibility, remained fully extended across the period of the simulation. In contrast, the same simulations conducted in the presence of one or two bound N-CEACAM1s and commencing with the straight form of UspA1(527-665) reproducibly showed distinctive bending was induced. This distortion rapidly led to distortions of 30-70degrees, similar to those observed in the SAXS envelopes.
###end p 31
###begin p 32
###xml 385 403 385 403 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 509 511 509 511 <italic>Mx</italic>
###xml 644 649 644 649 <italic>et al</italic>
###xml 636 655 636 655 <xref ref-type="bibr" rid="b15">Hoiczyk <italic>et al</italic>, 2000</xref>
###xml 732 734 732 734 <italic>Mx</italic>
###xml 884 902 884 902 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 509 511 <span type="species:ncbi:480">Mx</span>
###xml 732 734 <span type="species:ncbi:480">Mx</span>
By inference, this distorted model for the complex is also supported by the observation from both the AUC and ITC studies that only two molecules of N-CEACAM1 can bind each initially symmetrical trimer of UspA1. The absence of strong binding to the third site implies distortion of this remaining site, and hence of the UspA1 molecule. Finally, using transmission electron microscopy (Supplementary data), we have also observed that UspA1 appears to adopt not only extended structures in the surface array of Mx but significant perturbations also appear to be more prevalent in the presence of CEACAM1 receptor. Through gene deletions (Hoiczyk et al, 2000) it has previously been established that the most extended molecules at the Mx surface predominantly comprise UspA1. This demonstrates that both linear and distorted conformations of UspA1 are possible on the bacterial surface (Supplementary data). Although the resolution in these studies is insufficient to correlate the shapes observed directly with the structural model of the complex presented herein, these changes are consistent with the SAXS observations, and molecular dynamics simulations.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 196 207 196 207 <xref ref-type="bibr" rid="b24">Lupas, 1996</xref>
###xml 410 415 410 415 <italic>et al</italic>
###xml 403 421 403 421 <xref ref-type="bibr" rid="b45">Wilson <italic>et al</italic>, 1981</xref>
###xml 432 437 432 437 <italic>et al</italic>
###xml 423 443 423 443 <xref ref-type="bibr" rid="b3">Bullough <italic>et al</italic>, 1994</xref>
###xml 489 494 489 494 <italic>et al</italic>
###xml 484 500 484 500 <xref ref-type="bibr" rid="b7">Fass <italic>et al</italic>, 1996</xref>
###xml 536 541 536 541 <italic>et al</italic>
###xml 528 547 528 547 <xref ref-type="bibr" rid="b33">Sheriff <italic>et al</italic>, 1994</xref>
###xml 628 633 628 633 <italic>et al</italic>
###xml 619 639 619 639 <xref ref-type="bibr" rid="b29">Nummelin <italic>et al</italic>, 2004</xref>
###xml 1054 1063 1054 1063 <sup>(527&#8211;665)</sup>
###xml 1483 1501 1483 1501 <italic>Streptococcus equi</italic>
###xml 1623 1628 1623 1628 <italic>et al</italic>
###xml 1616 1634 1616 1634 <xref ref-type="bibr" rid="b25">Meehan <italic>et al</italic>, 2002</xref>
###xml 446 452 <span type="species:ncbi:10090">murine</span>
###xml 1457 1463 <span type="species:ncbi:9796">equine</span>
###xml 1483 1501 <span type="species:ncbi:1336">Streptococcus equi</span>
Coiled-coil motifs have been increasingly identified within a wide range of proteins and are believed to perform a variety of roles delivered by extended, relatively rigid structures (reviewed in Lupas, 1996). Although many coiled-coil proteins are dimeric, parallel trimeric coiled-coil structures have been reported for a number of viral and bacterial proteins, including the influenza hemagglutinin (Wilson et al, 1981; Bullough et al, 1994), murine leukaemia virus spike protein (Fass et al, 1996), mannose-binding protein (Sheriff et al, 1994) and in the stalk of the head group of the UspA1-related protein YadA (Nummelin et al, 2004). In all of these cases, the trimeric structure acts as a stalk to project other bio-active domains away from the pathogen membrane. In none of these cases, however, does the coiled-coil region itself act as ligand, instead playing a supporting structural role. The partial structure of UspA1 reported in this study is different. First, at about 200 A in length (double the extended hemagglutinin structure), UspA1(527-665) represents the longest stretch of trimeric coiled-coil for which a detailed structure is available. Second, UspA1 is unusual in utilising an extended stretch of regular coiled-coil as a receptor-binding domain. This is the first definitive example of this function for a trimeric coiled-coil, but it is likely there are others. For example, the M-like fibrinogen (Fg)-binding protein from the equine-specific bacterium Streptococcus equi has also previously been reported to contain an Fc-receptor-binding region within a multimeric coiled-coil stalk (Meehan et al, 2002), although no structural details are available.
###end p 34
###begin p 35
###xml 117 122 117 122 <italic>et al</italic>
###xml 109 129 109 129 <xref ref-type="bibr" rid="b15">Hoiczyk <italic>et al</italic> (2000)</xref>
###xml 134 152 134 152 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 385 394 385 394 <sup>(527&#8211;665)</sup>
###xml 1134 1139 1134 1139 <italic>et al</italic>
###xml 1126 1145 1126 1145 <xref ref-type="bibr" rid="b15">Hoiczyk <italic>et al</italic>, 2000</xref>
###xml 1260 1269 1260 1269 <sup>(527&#8211;665)</sup>
###xml 1598 1603 1598 1603 <italic>et al</italic>
###xml 1595 1609 1595 1609 <xref ref-type="bibr" rid="b47">Wu <italic>et al</italic>, 1997</xref>
###xml 1787 1804 1787 1804 <xref ref-type="bibr" rid="b11">Hammarstrom, 1999</xref>
###xml 2353 2362 2353 2362 <xref ref-type="fig" rid="f1">Figure 1B</xref>
###xml 938 943 <span type="species:ncbi:9606">human</span>
###xml 1492 1497 <span type="species:ncbi:9606">human</span>
The UspA1 protein is present at high density on the bacterial cell surface, and electron microscopy studies (Hoiczyk et al (2000) and Supplementary data) indicate this leads to forest-like densities in which the head groups may limit access to the closely packed stalk (trunk) regions. This arrangement is consistent with the linear structure observed for the uncomplexed form of UspA1(527-665) within the crystal lattice; maximisation of crystal contacts would be expected to favour this form. At the bacterial surface, close packing of adhesins might be encouraged by the hydrophobic nature of the ligand-binding site and may, through restricting access of large antibodies, confer some protection of this region from immune recognition. This arrangement, however, presents a problem in that the resulting physical locations of the respective ligand/receptor pair seem incongruous to permit sufficiently close approach of bacterial and human cell membranes to allow effective adherence via the CEACAM1-binding site. Electron microscopy studies indicate UspA1 extends approximately 600-700 A from the bacterial cell surface (Hoiczyk et al, 2000). This is consistent with the expected length of an extended coiled-coil segment (residues 333-742) of which UspA1(527-665) represents approximately one-third (200 A). In the fully extended intact ligand, the receptor-binding site would therefore be located at least 450 A from the membrane-distal end of UspA1. In contrast, its receptor site on human CEACAM1-by analogy with its similar construction to CD4 for which an overall structure is known (Wu et al, 1997)-can reach no further than about 120 A from the epithelial cell surface. Even if the receptor is primarily located within the highly invaginated microvilli of epithelial cells (Hammarstrom, 1999) the sheer bulk created by the length of the extended head group would seem to present a steric difficulty for placing the ligand and receptor in close proximity. Two explanations seem possible. The head group of UspA1 may insert into the epithelial cell membrane prior to attachment of CEACAM1, allowing the base of the stalk region to come into closer proximity to epithelial cell surface. Alternatively, as suggested by this study, the stalk of UspA1 is capable of changing conformation to allow closer approach of the two respective membranes (Figure 1B).
###end p 35
###begin p 36
###xml 143 152 143 152 <sup>(527&#8211;665)</sup>
###xml 533 542 527 536 <xref ref-type="fig" rid="f6">Figure 6A</xref>
###xml 650 659 644 653 <sup>(527&#8211;665)</sup>
###xml 1266 1275 1260 1269 <xref ref-type="fig" rid="f2">Figures 2</xref>
###xml 1280 1281 1274 1275 <xref ref-type="fig" rid="f6">6</xref>
###xml 2061 2063 2055 2057 <italic>Mx</italic>
###xml 2459 2468 2453 2462 <sup>(527&#8211;665)</sup>
###xml 2061 2063 <span type="species:ncbi:480">Mx</span>
Deformability of the UspA1 stalk region is demonstrated by the solution scattering studies, where in the presence of its CEACAM1 receptor UspA1(527-665) displays a distinctive curvature (bending angle of approximately 30-60degrees). This implies that in its receptor complex the UspA1 stalk has increased flexibility. Although self-aggregation prevents us from accurately interpreting similar solution scattering data collected in the absence of CEACAM1, the change in the scattering curve that accompanies addition of the receptor (Figure 6A) is consistent with an alteration in the molecular structure. Further, as the crystal structure shows UspA1(527-665) to be symmetrical there appears to be no inherent mechanism for it to adopt a discrete bend (an asymmetric structure) in the absence of other effectors. This is supported by the molecular dynamics simulations, which indicate that the extended structure exhibits a degree of flexibility, but remains rod-like overall. In contrast, the same simulations conducted in the presence of bound N-CEACAM1 reveal a 'weak spot' within the trimeric coiled-coil in the vicinity of residue 610, equidistant between the CEACAM1-binding site and the stutter and coincident with the incorporation of internally bound ions (Figures 2 and 6). Binding of N-CEACAM1, therefore, seems to provide a mechanism to 'break' the three-fold symmetry and hence encourage formation of the bowed structure. The asymmetry produced by the bending is likely to distort remaining binding sites generated by the inherent three-fold symmetry, accounting for the observation that a maximum of two N-CEACAM1 molecules readily associate with each UspA1 trimer. Binding of receptor may also disrupt interactions of this hydrophobic region with neighbouring copies of UspA1 (akin to disruption of aggregation in the SAXS studies). The observation of curvature of UspA1 when in complex with its receptor noted in the solution scattering studies is supported by (i) the molecular dynamics simulations; (ii) the electron microscopy studies of the Mx cell surface where significant perturbations of the adhesin 'forest' are observed and (iii) is a logical inference from the AUC and ITC measurements of a maximal stoichiometry of two molecules of N-CEACAM1 can bind with high affinity to each trimer of UspA1. In combination, these data support the concept of increased flexibility and the ability to adopt a distinctly bowed structure when UspA1(527-665) binds to its N-CEACAM1 receptor.
###end p 36
###begin p 37
###xml 175 184 175 184 <sup>(527&#8211;665)</sup>
###xml 688 693 688 693 <italic>et al</italic>
###xml 679 699 679 699 <xref ref-type="bibr" rid="b3">Bullough <italic>et al</italic>, 1994</xref>
###xml 1088 1093 1088 1093 <italic>et al</italic>
###xml 1080 1099 1080 1099 <xref ref-type="bibr" rid="b15">Hoiczyk <italic>et al</italic>, 2000</xref>
###xml 1104 1122 1104 1122 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 1159 1164 1159 1164 <italic>et al</italic>
###xml 1154 1170 1154 1170 <xref ref-type="bibr" rid="b32">Ruiz <italic>et al</italic>, 2006</xref>
It is possible that this potential for the stalk region of UspA1 to bend within this discrete region may arise from the internal histidines and/or the stutter within the UspA1(527-665) coiled-coil, which appear unique to this part of UspA1. The CD unfolding data highlight the marked instability of the coiled-coil structure to decreases in pH. Considering also the adjacent stutter, this whole region may be readily susceptible to the types of deformation seen in the SAXS analysis, molecular dynamics simulations and EM studies. By corollary, the extended triple coiled-coil in influenza hemagglutinin incorporates both buried histidines and several stutters along its length (Bullough et al, 1994) and is believed to be metastable-allowing a dramatic re-modelling to take place as the pH is changed. The stimulus that instigates the conformational change in UspA1-whether chemical or mechanical-is unknown. It is possible that the composition of this region simply makes it more susceptible to deformation in response to mechanical force. Electron microscopy studies of UspA1 (Hoiczyk et al, 2000 and Supplementary data) and the related protein EmaA (Ruiz et al, 2006) at their respective cell surfaces indicate that a variety of conformations are observed but distinctive kinks are evident in both cases. Bending may be initially required to allow access for the receptor, which then stabilises this conformation by breaking the three-fold symmetry of the UspA1 stalk.
###end p 37
###begin p 38
###xml 41 48 41 48 <italic>E. coli</italic>
###xml 186 191 186 191 <italic>et al</italic>
###xml 176 197 176 197 <xref ref-type="bibr" rid="b19">Korotkova <italic>et al</italic>, 2008</xref>
###xml 297 302 297 302 <italic>et al</italic>
###xml 287 308 287 308 <xref ref-type="bibr" rid="b19">Korotkova <italic>et al</italic>, 2008</xref>
###xml 614 619 614 619 <italic>et al</italic>
###xml 609 625 609 625 <xref ref-type="bibr" rid="b44">Watt <italic>et al</italic>, 2001</xref>
###xml 637 642 637 642 <italic>et al</italic>
###xml 627 648 627 648 <xref ref-type="bibr" rid="b19">Korotkova <italic>et al</italic>, 2008</xref>
###xml 41 48 <span type="species:ncbi:562">E. coli</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
A recent structural determination of the E. coli Dr adhesin bound to its human CEA receptor indicates that Dr also binds across the homo-dimer-forming surface of the receptor (Korotkova et al, 2008). This is very similar to the surface of CEACAM1 eclipsed by UspA1 in the current study (Korotkova et al, 2008). Note that the bacterium may achieve an advantage in targeting this largely invariant surface of the receptor. In both cases, it would be expected that adhesin binding would be accompanied by disruption of the homo- and heterophilic interactions known to occur between members of the CEACAM family (Watt et al, 2001; Korotkova et al, 2008).
###end p 38
###begin p 39
###xml 50 55 50 55 <italic>et al</italic>
###xml 46 61 46 61 <xref ref-type="bibr" rid="b36">Tan <italic>et al</italic>, 2006</xref>
###xml 128 133 128 133 <italic>et al</italic>
###xml 124 139 124 139 <xref ref-type="bibr" rid="b37">Tan <italic>et al</italic>, 2005</xref>
###xml 589 598 589 598 <sup>(527&#8211;665)</sup>
###xml 634 636 634 636 <italic>Mx</italic>
###xml 638 640 638 640 <italic>Nm</italic>
###xml 645 647 645 647 <italic>Hi</italic>
###xml 723 725 723 725 <italic>Mx</italic>
###xml 748 753 748 753 <italic>et al</italic>
###xml 743 759 743 759 <xref ref-type="bibr" rid="b13">Hill <italic>et al</italic>, 2005</xref>
###xml 634 636 <span type="species:ncbi:480">Mx</span>
###xml 638 640 <span type="species:ncbi:487">Nm</span>
###xml 645 647 <span type="species:ncbi:727">Hi</span>
###xml 723 725 <span type="species:ncbi:480">Mx</span>
UspA1 is also known to interact with laminin (Tan et al, 2006), a component of the basement membrane, and with fibronectin (Tan et al, 2005), which is prevalent in the extracellular matrix. Both these activities have been localised to the head group or nearby region. It is not known whether UspA1 can bind these ligands simultaneously in addition to CEACAM1. Further studies are required to provide a composite model for the multi-functional behaviour of UspA1, including its dynamic responses to the mechanical forces encountered as the bacterium encounters its host cell. Finally, UspA1(527-665) has been shown to block binding of Mx, Nm and Hi clinical isolates and to generate a protective immune response against all Mx isolates tested (Hill et al, 2005). From the identification of the N-CEACAM1-binding site and its molecular structure provided by these studies, it may now be possible to engineer smaller constructs with valuable therapeutic applications.
###end p 39
###begin title 40
Materials and methods
###end title 40
###begin title 41
Bacterial strains
###end title 41
###begin p 42
###xml 4 18 4 18 <italic>M. catarrhalis</italic>
###xml 96 116 96 116 <xref ref-type="bibr" rid="b14">Hill and Virji, 2003</xref>
###xml 123 128 123 128 <italic>et al</italic>
###xml 118 134 118 134 <xref ref-type="bibr" rid="b13">Hill <italic>et al</italic>, 2005</xref>
###xml 4 18 <span type="species:ncbi:480">M. catarrhalis</span>
The M. catarrhalis strains MX2 ATCC 25238 and 035E were grown as described in previous studies (Hill and Virji, 2003; Hill et al, 2005).
###end p 42
###begin title 43
Recombinant protein purification and ELISA
###end title 43
###begin p 44
###xml 36 45 36 45 <sup>(527&#8211;665)</sup>
###xml 82 87 82 87 <italic>et al</italic>
###xml 77 93 77 93 <xref ref-type="bibr" rid="b13">Hill <italic>et al</italic>, 2005</xref>
###xml 110 119 110 119 <sup>(527&#8211;665)</sup>
###xml 298 303 298 303 <italic>et al</italic>
###xml 287 310 287 310 <xref ref-type="bibr" rid="b8">Fedarovich <italic>et al</italic> (2006)</xref>
###xml 324 333 324 333 <sup>(527&#8211;665)</sup>
###xml 388 406 388 406 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 556 561 556 561 <italic>et al</italic>
###xml 550 567 550 567 <xref ref-type="bibr" rid="b40">Virji <italic>et al</italic>, 1999</xref>
###xml 579 584 579 584 <italic>et al</italic>
###xml 569 590 569 590 <xref ref-type="bibr" rid="b39">Villullas <italic>et al</italic>, 2007</xref>
Expression and purification of UspA1(527-665) has been described previously (Hill et al, 2005). Refolded UspA1(527-665) was purified further by GPC on an XK16/60 Superdex 75 column (GE Healthcare) in 50 mM Tris, pH 8.0 and 150 mM NaCl. Recombinant N-CEACAM1 was prepared as described in Fedarovich et al (2006). Mutant UspA1(527-665), and N-CEACAM1 proteins were prepared as described in Supplementary data. The production of soluble CEACAM1-Fc receptor, NA1B-Fc construct and receptor-binding ELISA used in this study has been described previously (Virji et al, 1999; Villullas et al, 2007).
###end p 44
###begin title 45
AUC
###end title 45
###begin p 46
###xml 97 102 97 102 <italic>et al</italic>
###xml 90 108 90 108 <xref ref-type="bibr" rid="b27">Murphy <italic>et al</italic>, 2006</xref>
###xml 182 191 182 191 <sup>(527&#8211;665)</sup>
###xml 221 230 221 230 <sup>(527&#8211;665)</sup>
Sedimentation equilibrium experiments were performed using a method previously described (Murphy et al, 2006). CEACAM1 (0.36 mg/ml) was in 50 mM Hepes (pH 8.0), 150 mM NaCl and UspA1(527-665) (0.13 mg/ml) or CEACAM1/UspA1(527-665) complex (0.07 mg/ml) in 50 mM Tris (pH 8.0) and 150 mM NaCl. In each case, the corresponding buffer was used as a reference. Data were collected at rotor speeds of 10 000, 16 000 and 25 000 r.p.m. after 20 and 24 h by measuring absorbance at 230 or 280 nm, as a function of the radius of centrifugation.
###end p 46
###begin title 47
Isothermal titration calorimetry
###end title 47
###begin p 48
###xml 31 40 31 40 <sup>(527&#8211;665)</sup>
###xml 149 158 143 152 <sup>(527&#8211;665)</sup>
###xml 655 656 645 646 <italic>N</italic>
###xml 672 673 660 661 <italic>K</italic>
###xml 673 674 661 662 <sub>D</sub>
###xml 709 710 695 696 <italic>N</italic>
###xml 725 726 709 710 <italic>K</italic>
###xml 726 727 710 711 <sub>D</sub>
Complex formation between UspA1(527-665) and N-CEACAM1 was measured using a VP-ITC microcalorimeter (MicroCal) at 37degreesC. In the first run, UspA1(527-665) at 4 muM in 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, was titrated with a 47 muM solution of N-CEACAM1 in the same buffer in 25 steps of 10 mul; these concentrations were 5 and 100 muM, respectively, in the second run. The raw data were corrected for the competing dimerisation of N-CEACAM1. Data from each of these two runs were analysed using the Origin V5.0 ITC Analysis software assuming a single type of binding and without fixing the number of ligand molecules. The data from the first run gave N=2.1+/-0.1 with KD=35+/-13 nM, and in the second run N=1.9+/-0.1 and KD=12+/-10.
###end p 48
###begin title 49
Structural studies
###end title 49
###begin p 50
###xml 26 35 26 35 <sup>(527&#8211;665)</sup>
###xml 179 197 179 197 <xref ref-type="supplementary-material" rid="S1">Supplementary data</xref>
###xml 271 278 271 278 <xref ref-type="table" rid="t1">Table I</xref>
Determination of the UspA1(527-665) crystal structure, SAXS experiments, molecular modelling and electron microscopy studies were performed using standard methods as described in Supplementary data. X-ray data collection and final refinement statistics are summarised in Table I.
###end p 50
###begin title 51
Coordinate deposit
###end title 51
###begin p 52
###xml 46 53 46 53 <sup>527&#8211;665</sup>
Coordinates and structure factors of the UspA1527-665 crystal structure have been deposited with the RCSB Protein Data Bank (accession code 2QIH), and coordinates of the complex are available from .
###end p 52
###begin title 53
Supplementary Material
###end title 53
###begin p 54
Supplementary data 1
###end p 54
###begin p 55
Supplementary data 2
###end p 55
###begin p 56
Supplementary data 3
###end p 56
###begin p 57
Supplementary data 5
###end p 57
###begin p 58
Supplementary data 6
###end p 58
###begin p 59
Supplementary movie S1
###end p 59
###begin p 60
Supplementary movie S2
###end p 60
###begin p 61
Supplementary movie S3
###end p 61
###begin p 62
We thank Dr Tim Joseph-Horne and Dr Aew Chaikuad for assistance with molecular biology and ITC, Natalie Griffiths for technical assistance, the staff at EMBL Grenoble Outstation-especially Hassan Belrhali-for providing support for measurements at the ESRF under the European 'Research Infrastructure Action FP6 Program', staff at the Daresbury SRS for access to synchrotron facilities and Dr Chris Davies (MUSC) for supply of one of the N-CEACAM1 constructs. This study was supported by a grant from the Wellcome Trust (Ref: 07746), and partly conducted in the Spencer Dayman Meningitis Laboratories.
###end p 62
###begin article-title 63
###xml 59 80 59 80 <italic>Moraxella catarrhalis</italic>
###xml 59 80 <span type="species:ncbi:480">Moraxella catarrhalis</span>
Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E.
###end article-title 63
###begin article-title 64
###xml 21 42 21 42 <italic>Moraxella catarrhalis</italic>
###xml 21 42 <span type="species:ncbi:480">Moraxella catarrhalis</span>
The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.
###end article-title 64
###begin article-title 65
Structure of influenza haemagglutinin at the pH of membrane fusion.
###end article-title 65
###begin article-title 66
###xml 24 45 24 45 <italic>Moraxella catarrhalis</italic>
###xml 24 45 <span type="species:ncbi:480">Moraxella catarrhalis</span>
Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products.
###end article-title 66
###begin article-title 67
###xml 108 124 <span type="species:ncbi:227859">SARS coronavirus</span>
Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein.
###end article-title 67
###begin article-title 68
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 127 148 <span type="species:ncbi:11138">mouse hepatitis virus</span>
Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59.
###end article-title 68
###begin article-title 69
Retrovirus envelope domain at 1.7 angstrom resolution.
###end article-title 69
###begin article-title 70
###xml 111 133 111 133 <italic>Neisseria meningitidis</italic>
###xml 138 152 138 152 <italic>N. gonorrhoeae</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 111 133 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 138 152 <span type="species:ncbi:485">N. gonorrhoeae</span>
Structure of the N-terminal domain of human CEACAM1: binding target of the opacity proteins during invasion of Neisseria meningitidis and N. gonorrhoeae.
###end article-title 70
###begin article-title 71
###xml 39 61 39 61 <italic>Neisseria meningitidis</italic>
###xml 39 61 <span type="species:ncbi:487">Neisseria meningitidis</span>
IFN-gamma amplifies NFkappaB-dependent Neisseria meningitidis invasion of epithelial cells via specific upregulation of CEA-related cell adhesion molecule 1.
###end article-title 71
###begin article-title 72
###xml 155 171 155 171 <italic>Escherichia coli</italic>
###xml 155 171 <span type="species:ncbi:562">Escherichia coli</span>
###xml 188 193 <span type="species:ncbi:9606">human</span>
Recruitment of CD55 and CD66e brush border-associated glycosylphosphatidylinositol-anchored proteins by members of the Afa/Dr diffusely adhering family of Escherichia coli that infect the human polarized intestinal Caco-2/TC7 cells.
###end article-title 72
###begin article-title 73
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.
###end article-title 73
###begin article-title 74
###xml 30 38 30 38 <italic>Yersinia</italic>
Identification of a domain in Yersinia virulence factor YadA that is crucial for extracellular matrix-specific cell adhesion and uptake.
###end article-title 74
###begin article-title 75
Carcinoembryonic antigen-related cell adhesion molecule (CEACAM)-binding recombinant polypeptide confers protection against infection by respiratory and urogenital pathogens.
###end article-title 75
###begin article-title 76
###xml 34 55 34 55 <italic>Moraxella catarrhalis</italic>
###xml 34 55 <span type="species:ncbi:480">Moraxella catarrhalis</span>
A novel cell-binding mechanism of Moraxella catarrhalis ubiquitous surface protein UspA: specific targeting of the N-domain of carcinoembryonic antigen-related cell adhesion molecules by UspA1.
###end article-title 76
###begin article-title 77
###xml 35 43 35 43 <italic>Yersinia</italic>
###xml 53 62 53 62 <italic>Moraxella</italic>
Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins.
###end article-title 77
###begin article-title 78
###xml 0 21 0 21 <italic>Moraxella catarrhalis</italic>
###xml 0 21 <span type="species:ncbi:480">Moraxella catarrhalis</span>
###xml 48 53 <span type="species:ncbi:9606">human</span>
Moraxella catarrhalis: a review of an important human mucosal pathogen.
###end article-title 78
###begin article-title 79
Sedimentation behavior of chemically reacting systems.
###end article-title 79
###begin article-title 80
###xml 65 88 65 88 <italic>Yersinia enterocolitica</italic>
###xml 65 88 <span type="species:ncbi:630">Yersinia enterocolitica</span>
Model structure of the prototypical non-fimbrial adhesin YadA of Yersinia enterocolitica.
###end article-title 80
###begin article-title 81
###xml 26 42 26 42 <italic>Escherichia coli</italic>
###xml 26 42 <span type="species:ncbi:562">Escherichia coli</span>
Binding of Dr adhesins of Escherichia coli to carcinoembryonic antigen triggers receptor dissociation.
###end article-title 81
###begin article-title 82
###xml 74 95 74 95 <italic>Moraxella catarrhalis</italic>
###xml 122 130 122 130 <italic>in vitro</italic>
###xml 74 95 <span type="species:ncbi:480">Moraxella catarrhalis</span>
###xml 99 104 <span type="species:ncbi:9606">human</span>
The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro.
###end article-title 82
###begin article-title 83
###xml 11 27 11 27 <italic>Escherichia coli</italic>
###xml 32 42 32 42 <italic>Salmonella</italic>
###xml 11 27 <span type="species:ncbi:562">Escherichia coli</span>
Binding of Escherichia coli and Salmonella strains to members of the carcinoembryonic antigen family: differential binding inhibition by aromatic alpha-glycosides of mannose.
###end article-title 83
###begin article-title 84
Trimeric autotransporter adhesins: variable structure, common function.
###end article-title 84
###begin article-title 85
Structure validation by Calpha geometry: phi, psi and Cbeta deviation.
###end article-title 85
###begin article-title 86
Coiled coils: new structures and new functions.
###end article-title 86
###begin article-title 87
###xml 60 78 60 78 <italic>Streptococcus equi</italic>
###xml 86 90 86 90 <italic>equi</italic>
###xml 60 90 <span type="species:ncbi:148942">Streptococcus equi subsp. equi</span>
The C-terminal portion of the fibrinogen-binding protein of Streptococcus equi subsp. equi contains extensive alpha-helical coiled-coil structure and contributes to thermal stability.
###end article-title 87
###begin article-title 88
###xml 59 81 59 81 <italic>Haemophilus influenzae</italic>
###xml 59 81 <span type="species:ncbi:727">Haemophilus influenzae</span>
Structure of the outer membrane translocator domain of the Haemophilus influenzae Hia trimeric autotransporter.
###end article-title 88
###begin article-title 89
###xml 21 43 21 43 <italic>Pseudomonas aeruginosa</italic>
###xml 21 43 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Crystal structure of Pseudomonas aeruginosa SPM-1 provides insights into variable zinc affinity of metallo-beta-lactamases.
###end article-title 89
###begin article-title 90
###xml 22 43 22 43 <italic>Moraxella catarrhalis</italic>
###xml 22 43 <span type="species:ncbi:480">Moraxella catarrhalis</span>
The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2.
###end article-title 90
###begin article-title 91
###xml 4 12 4 12 <italic>Yersinia</italic>
The Yersinia adhesin YadA collagen-binding domain structure is a novel left-handed parallel beta-roll.
###end article-title 91
###begin article-title 92
Structure of the translocator domain of a bacterial autotransporter.
###end article-title 92
###begin article-title 93
Global rigid body modeling of macromolecular complexes against small-angle scattering data.
###end article-title 93
###begin article-title 94
###xml 61 97 61 97 <italic>Actinobacillus actinomycetemcomitans</italic>
###xml 61 97 <span type="species:ncbi:714">Actinobacillus actinomycetemcomitans</span>
Novel surface structures are associated with the adhesion of Actinobacillus actinomycetemcomitans to collagen.
###end article-title 94
###begin article-title 95
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil.
###end article-title 95
###begin article-title 96
CRYSOL-a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates.
###end article-title 96
###begin article-title 97
Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing.
###end article-title 97
###begin article-title 98
###xml 25 46 25 46 <italic>Moraxella catarrhalis</italic>
###xml 25 46 <span type="species:ncbi:480">Moraxella catarrhalis</span>
The respiratory pathogen Moraxella catarrhalis binds to laminin via ubiquitous surface proteins A1 and A2.
###end article-title 98
###begin article-title 99
###xml 25 46 25 46 <italic>Moraxella catarrhalis</italic>
###xml 25 46 <span type="species:ncbi:480">Moraxella catarrhalis</span>
The respiratory pathogen Moraxella catarrhalis adheres to epithelial cells by interacting with fibronectin through ubiquitous surface proteins A1 and A2.
###end article-title 99
###begin article-title 100
###xml 13 29 <span type="species:ncbi:10665">bacteriophage T4</span>
Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain.
###end article-title 100
###begin article-title 101
###xml 23 28 <span type="species:ncbi:9606">human</span>
Mutational analysis of human CEACAM1: the potential of receptor polymorphism in increasing host susceptibility to bacterial infection.
###end article-title 101
###begin article-title 102
###xml 52 74 52 74 <italic>Neisseria meningitidis</italic>
###xml 79 100 79 100 <italic>Neisseria gonorrhoeae</italic>
###xml 52 74 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 79 100 <span type="species:ncbi:485">Neisseria gonorrhoeae</span>
Critical determinants of host receptor targeting by Neisseria meningitidis and Neisseria gonorrhoeae: identification of Opa adhesiotopes on the N-domain of CD66 molecules.
###end article-title 102
###begin article-title 103
###xml 82 104 82 104 <italic>Neisseria meningitidis</italic>
###xml 109 130 109 130 <italic>Neisseria gonorrhoeae</italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 82 104 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 109 130 <span type="species:ncbi:485">Neisseria gonorrhoeae</span>
The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae.
###end article-title 103
###begin article-title 104
###xml 14 23 14 23 <italic>ab initio</italic>
Uniqueness of ab initio shape determination in small-angle scattering.
###end article-title 104
###begin article-title 105
Socket: a program for identifying and analysing coiled-coil motifs within protein structures.
###end article-title 105
###begin article-title 106
###xml 23 28 <span type="species:ncbi:9606">human</span>
Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site.
###end article-title 106
###begin article-title 107
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.
###end article-title 107
###begin article-title 108
Purification of the YadA membrane anchor for secondary structure analysis and crystallization.
###end article-title 108
###begin article-title 109
###xml 66 71 <span type="species:ncbi:9606">human</span>
Dimeric association and segmental variability in the structure of human CD4.
###end article-title 109
###begin article-title 110
###xml 45 67 45 67 <italic>Haemophilus influenzae</italic>
###xml 45 67 <span type="species:ncbi:727">Haemophilus influenzae</span>
Structural basis for host recognition by the Haemophilus influenzae Hia autotransporter.
###end article-title 110
###begin p 111
###xml 21 22 21 22 <bold>A</bold>
###xml 281 286 281 286 <italic>et al</italic>
###xml 277 292 277 292 <xref ref-type="bibr" rid="b37">Tan <italic>et al</italic>, 2005</xref>
###xml 347 352 347 352 <italic>et al</italic>
###xml 343 358 343 358 <xref ref-type="bibr" rid="b36">Tan <italic>et al</italic>, 2006</xref>
###xml 397 402 397 402 <italic>et al</italic>
###xml 388 408 388 408 <xref ref-type="bibr" rid="b29">Nummelin <italic>et al</italic>, 2004</xref>
###xml 623 628 623 628 <italic>et al</italic>
###xml 620 634 620 634 <xref ref-type="bibr" rid="b47">Wu <italic>et al</italic>, 1997</xref>
###xml 686 687 686 687 <bold>B</bold>
Schematic of UspA1. (A) The arrangement of proposed domains in UspA1 with the approximate regions of the binding sites for CEACAM1, laminin and fibronectin is shown. The latter two are located in the N-terminal region (UspA1 residues 299-452 and UspA2 165-318 for fibronectin (Tan et al, 2005), and UspA1 299-452 and UspA2 30-177 for laminin (Tan et al, 2006)), and by analogy with YadA (Nummelin et al, 2004) are likely to be within the head group. The bacterial cell membrane is at the bottom of the schematic. CEACAM1 is shown approximately to scale (represented here by the crystal structure of similarly sized CD4; Wu et al, 1997) bound to an epithelial cell membrane (top left). (B) Proposed model for bending of UspA1 in association with binding of CEACAM1 to allow adhesion and infection, as supported by the current study.
###end p 111
###begin p 112
###xml 30 39 30 39 <sup>(527&#8211;665)</sup>
###xml 42 43 42 43 <bold>A</bold>
###xml 71 80 71 80 <sup>(527&#8211;665)</sup>
###xml 265 266 261 262 <bold>B</bold>
###xml 478 479 474 475 <bold>C</bold>
###xml 531 532 527 528 <italic>F</italic>
###xml 532 535 528 531 <sub>obs</sub>
###xml 536 537 532 533 <italic>F</italic>
###xml 537 541 533 537 <sub>calc</sub>
###xml 609 610 601 602 <bold>D</bold>
###xml 727 728 719 720 <bold>E</bold>
###xml 768 777 760 769 <sup>(527&#8211;665)</sup>
###xml 906 915 898 907 <sup>(527&#8211;665)</sup>
The crystal structure of UspA1(527-665). (A) Crystal structure of UspA1(527-665) shown as a Calpha ribbon trace with chain A in yellow, chain B in red and chain C in blue. The amino terminus (N) of each chain is on the left, and carboxy terminus (C) on the right. (B) Hydrogen bonding interactions for the three internal histidine residues. Chain A in orange, chain B in pink and chain C in cyan. Their approximate location in the overall structure is indicated by the arrows. (C) Stereo view for representative electron density (2Fobs-Fcalc, contoured at 1sigma) corresponding to the buried His 629 region. (D) Locations of internally bound phosphate (orange) and chloride (green) ions within the central coiled-coil cavity. (E) Overall electrostatic surface of UspA1(527-665). The hydrophobic patch proposed to be the receptor-binding site is indicated by the blue bar. The scale and orientation of UspA1(527-665) is the same throughout (A, D, E).
###end p 112
###begin p 113
###xml 34 35 34 35 <bold>A</bold>
###xml 58 67 58 67 <sup>(527&#8211;665)</sup>
###xml 98 99 98 99 <bold>B</bold>
###xml 127 136 127 136 <sup>(527&#8211;665)</sup>
###xml 211 212 211 212 <bold>C</bold>
Circular dichroism (CD) spectra. (A) CD spectra from UspA1(527-665) across a range of pH values. (B) CD spectra of native UspA1(527-665) (solid diamonds) compared with the M586A/A588Q mutant (solid triangles). (C) Melting curves for native (solid diamonds) and the mutant (solid triangles) proteins measured by monitoring absorbance at 222 nm against increasing time and temperature (2degreesC increases in temperature every 180 s from 29 to 47degreesC). All spectra were obtained at room temperature at 0.1 mg/ml in 50 mM phosphate-acetate buffer using a Jobin-Yvon CD6 spectropolarimeter, and are an average of at least two scans after substraction of the spectra of the buffer.
###end p 113
###begin p 114
###xml 22 31 22 31 <sup>(527&#8211;665)</sup>
###xml 52 53 52 53 <bold>A</bold>
###xml 110 119 110 119 <sup>(527&#8211;665)</sup>
###xml 153 162 153 162 <sup>(527&#8211;665)</sup>
###xml 351 360 351 360 <sup>(527&#8211;665)</sup>
###xml 420 429 414 423 <sup>(527&#8211;665)</sup>
###xml 511 512 505 506 <bold>B</bold>
###xml 619 628 613 622 <sup>(527&#8211;665)</sup>
###xml 899 900 887 888 <italic>M</italic>
###xml 938 943 926 931 <italic>et al</italic>
###xml 931 949 919 937 <xref ref-type="bibr" rid="b27">Murphy <italic>et al</italic>, 2006</xref>
###xml 1057 1058 1045 1046 <italic>M</italic>
###xml 1214 1215 1196 1197 <bold>C</bold>
###xml 1260 1269 1242 1251 <sup>(527&#8211;665)</sup>
###xml 1324 1325 1306 1307 <italic>K</italic>
###xml 1325 1326 1307 1308 <sub>D</sub>
###xml 1334 1335 1316 1317 <italic>N</italic>
###xml 1530 1553 1512 1535 <italic>The EMBO Journal Online</italic>
Formation of the UspA1(527-665)/N-CEACAM1 complex. (A) GPC analysis. Samples of N-CEACAM1 (blue, right), UspA1(527-665) (red, middle) and N-CEACAM1/UspA1(527-665) complex (green, left) were run individually on an XK16/60 Superdex 75 column in 50 mM Na Hepes, pH 8.0 and 150 mM NaCl. The complex was formed by incubating amounts equivalent to one UspA1(527-665) trimer to one N-CEACAM1 dimer at 18degreesC for 16 h. UspA1(527-665) absorbs poorly at 280 nm due to the absence of tyrosine and tryptophan resides. (B) AUC sedimentation equilibrium analysis. The main panels show the absorbance for (i) N-CEACAM1, (ii) UspA1(527-665) and (iii) complex, as a function of the radius of centrifugation, following centrifugation at 20degreesC for 24 h at 16 000 r.p.m. The absorbance was recorded at 280 nm in (i) and at 230 nm in (ii) and (iii). In each case, the fitted line corresponds to a global fit to M in Equation (1) of reference (Murphy et al, 2006) for multiple datasets at a range of speeds (see Materials and methods). The best fit was obtained with an M for (i) 27 237+/-976; for (ii) 43 896+/-590 and (iii) 74 162+/-912. The upper panels show the distribution of the residuals between the data and the fit. (C) ITC analysis. Isothermal titration of UspA1(527-665) with N-CEACAM1 shows an initial strong binding event (KD=35 nM, N=2) followed by apparent weak association events that may result from the weaker ligand dimerisation. The inset shows raw titration data. A full-colour version of this figure is available at the The EMBO Journal Online.
###end p 114
###begin p 115
###xml 35 44 35 44 <sup>(527&#8211;665)</sup>
###xml 63 64 63 64 <bold>A</bold>
###xml 272 281 266 275 <sup>(527&#8211;665)</sup>
###xml 453 454 447 448 <bold>B</bold>
###xml 554 563 548 557 <xref ref-type="fig" rid="f2">Figure 2,</xref>
###xml 603 604 597 598 <bold>C</bold>
###xml 621 630 615 624 <sup>(527&#8211;665)</sup>
###xml 718 727 712 721 <sup>(527&#8211;665)</sup>
###xml 827 828 820 821 <italic>K</italic>
###xml 828 829 821 822 <sub>D</sub>
###xml 1012 1013 1005 1006 <italic>n</italic>
###xml 1050 1059 1041 1050 <sup>(527&#8211;665)</sup>
###xml 1221 1230 1211 1220 <sup>(527&#8211;665)</sup>
Site-directed mutagenesis and UspA1(527-665)/CEACAM1 binding. (A) Location of residues shown to affect binding on the surface of the crystal structures shown after opening of the model interface for the complex (rotated 180degrees around an axis across the page) for UspA1(527-665) (bottom) and for N-CEACAM1 (top). Mutated residues generating a large reduction in binding are shown in red, medium in orange, moderate in yellow and no effect in green. (B) Location of the interface residues in the model of the assembled complex. UspA1 is coloured as in Figure 2, and the N-CEACAM1 molecules in green. (C) Effect of UspA1(527-665) amino-acid substitutions on CEACAM1-Fc binding. (i) ELISA: microwells coated with UspA1(527-665) constructs at concentrations shown and binding was assessed using receptor at 0.5 mug/ml. Apparent KD values calculated where possible are also shown. (ii) The constructs were overlaid with anti-polyhistidine antibody to indicate the amounts that are present in the assay. Data shown n=4+/-s.e. (iii) Western blot of UspA1(527-665) constructs as indicated overlaid with CEACAM1-Fc (0.5 mug/ml) corroborates the ELISA data. CEACAM1 bound both the monomers (M) and the oligomers (O) of the UspA1(527-665) constructs. The relative CEACAM1 binding in (iii) determined by densitometric analysis is shown in (iv).
###end p 115
###begin p 116
###xml 31 40 31 40 <sup>(527&#8211;665)</sup>
###xml 59 60 59 60 <bold>A</bold>
###xml 119 128 119 128 <sup>(527&#8211;665)</sup>
###xml 294 303 294 303 <sup>(527&#8211;665)</sup>
###xml 328 329 328 329 <bold>B</bold>
###xml 331 332 331 332 <bold>C</bold>
###xml 397 405 397 405 <xref ref-type="fig" rid="f5">Figure 5</xref>
###xml 504 528 504 528 <xref ref-type="bibr" rid="b42">Volkov and Svergun, 2003</xref>
###xml 532 533 532 533 <bold>D</bold>
Solution structure of the UspA1(527-665)/CEACAM1 complex. (A) Experimental SAXS scattering curve (black dots) for UspA1(527-665)/CEACAM1 complex overlaid with the fits of the envelope (yellow), bent (red) and straight (green) complex models shown below. The scattering data for unliganded UspA1(527-665) is shown as blue dots. (B, C) Two orthogonal views of the bent complex model (coloured as in Figure 5) superimposed on this envelope, which is the median reconstruction selected by DAMAVER are shown (Volkov and Svergun, 2003). (D) The same model without the envelope is shown.
###end p 116
###begin p 117
###xml 72 81 72 81 <sup>(527&#8211;665)</sup>
Summary of X-ray diffraction data and refined model statistics for UspA1(527-665)
###end p 117

